NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
FDA warnings to the product labeling for the following contrast agents:
Gadolinium based contrast agents - The FDA has requested manufacturers of all gadolinium based contrast agents to add new warnings about exposure to gadolinium based contrast agents, which increases the risk for nephrogenic systemic fibrosis in patients with advanced kidney disease. The full text of the warning is available at: http://www.fda.gov/cder/drug/infopage/gcca/default.htm
- United States Food and Drug Administration (FDA) Warnings - Molecular Imaging an...United States Food and Drug Administration (FDA) Warnings - Molecular Imaging and Contrast Agent Database (MICAD)
- PREDICTED: transcription initiation protein SPT3 homolog [Saccoglossus kowalevsk...PREDICTED: transcription initiation protein SPT3 homolog [Saccoglossus kowalevskii]gi|585721619|ref|XP_006813301.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...